Clinical Trial Update: Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates penpulimab in combination with chemotherapy, with or without anlotinib, for patients with advanced esophageal squamous cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Anlotinib (anlotinib)
• Penpulimab

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING